FierceBiotech22h
Boston Pharma hits phase 2 MASH goal, positioning monthly prospect to follow Akero, 89bio into pivotal trials
Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...
FierceBiotech19h
Innate Pharma antibody pits natural killer cells against cancerous B cells in mice and monkeys
French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...
FierceBiotech22h
Philips obtains FDA clearance for radiotherapy scanner combining 4D and spectral CT in one scan
Philips has secured an FDA clearance for what it describes as the world’s first imager to combine spectral CT with ...